Dergiler / Klinik Psikofarmakoloji Bülteni / 2016 / Cilt: 26 - Sayı: 2

Sudden death associated with hypersensitivity myocarditis induced by clozapine: An autopsy case

Sayfa
186–190
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Drug-induced eosinophilic hypersensitivity myocarditis should be considered in the sudden death cases with a history of clozapine use and/or in presence of clozapine in the toxicological analysis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Eosinophilic myocarditis is a rare cause of sudden unexpected death and characterized by eosinophilic infiltration in the myocardium.
📊
Temel Bulgular & Veri:Our case is a 48 year-old female patient who was hospitalized in psychiatry inpatient unit and died unexpectedly on the 35th day of her hospitalization while on clozapine treatment.
💡
Sonuç & Katkı:Drug-induced eosinophilic hypersensitivity myocarditis should be considered in the sudden death cases with a history of clozapine use and/or in presence of clozapine in the toxicological analysis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Eosinophilic myocarditis is a rare cause of sudden unexpected death and characterized by eosinophilic infiltration in the myocardium. Clozapine is among the agents that can cause eosinophilic myocarditis. Our case is a 48 year-old female patient who was hospitalized in psychiatry inpatient unit and died unexpectedly on the 35th day of her hospitalization while on clozapine treatment. Even though the autopsy revealed an increased heart weight, fatty streaks on aorta, and thickening of epicardial fat tissue macroscopically, no pathological macroscopic features were noted in the myocardial cross sections. Eosinophilic myocarditis findings were found in the histopathological evaluation. Toxicological assessment revealed presence of clozapine in the blood (735ng/ml clozapine and its metabolite) and the bile. In the lights of these findings, it was concluded that the patient died from clozapine-induced eosinophilic hypersensitivity myocarditis. Drug-induced eosinophilic hypersensitivity myocarditis should be considered in the sudden death cases with a history of clozapine use and/or in presence of clozapine in the toxicological analysis.

🔖

Bu Makaleye Atıf Yap

EŞ, H., MELEZ, I. E., OZGUN, A., MELEZ, D. O., KERTMEN, C., CAVLAK, M. (2022). Sudden death associated with hypersensitivity myocarditis induced by clozapine: An autopsy case. Klinik Psikofarmakoloji Bülteni, Cilt: 26 - Sayı: 2, 186–190. https://ajindex.com/articles/572634

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Martinez S, Miranda E, Kim P, Pollanen MS. Giant cell myocarditis associated with amoxicillin hypersensitivity reaction. Forensic Sci Med Pathol 2013
  2. 9(3):403-6. [CrossRef] 2. Fragkouli K, Mitselou A, Boumba V, Michalis L, Vougiouklakis T. An autopsy case of necrotizing eosinophilic myocarditis causing left ventricular wall rupture. Forensic Sci Med Pathol 2011
  3. 7(4):350-4. [CrossRef] 3. Hara T, Yamaguchi K, Iwase T, Kadota M, Bando M, Ogasawara K, et al. Eosinophilic myocarditis due to ChurgStrauss syndrome with markedly elevated eosinophil cationic protein. Int Heart J 2013
  4. 54(1):51-3. [CrossRef] 4. Sagar S, Liu PP, Cooper LT Jr. Myocarditis. Lancet 2012
  5. 379(9817):738-47. [CrossRef] 5. Fineschi V, Neri M, Riezzo I, Turillazzi E. Sudden cardiac death due to hypersensitivity myocarditis during clozapine treatment. Int J Legal Med 2004
  6. 118(5):307-9. [CrossRef] 6. Merrill DB, Ahmari SE, Bradford JME, Lieberman JA. Myocarditis during clozapine treatment. Am J Psychiatry 2006
  7. 163(2):204-8. [CrossRef] 7. Hangartner JR, Marley NJ, Whitehead A, Thomas AC, Davies MJ. The assessment of cardiac hypertrophy at autopsy. Histopathology 1985
  8. 9(12):1295-306. [CrossRef] 8. Uges DRA.TIAFT reference blood level list of therapeutic and toxic substances. TIAFT [Internet]. 2004 Sep [cited 2015 May 12]
  9. Available from: www.tiaft.org/ 9. Weber MA, Ashworth MT, Risdon RA, Malone M, Burch M, Sebire NJ. Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series. Arch Dis Child 2008
  10. 93(7):594-8. [CrossRef] 10. Ginsberg F, Parrillo JE. Eosinophilic myocarditis. Heart Fail Clin 2005
  11. 1(3):419-29. [CrossRef] 11. Taliercio CP, Olney BA, Lie JT. Myocarditis related to drug hypersensitivity. Mayo Clin Proc 1985
  12. 60(7):463-8. [CrossRef] 12. Takkenberg JJ, Czer LS, Fishbein MC, Luthringer DJ, Quartel AW, Mirocha J, et al. Eosinophilic myocarditis in patients awaiting heart transplantation. Crit Care Med 2004
  13. 32(3):714- 21. [CrossRef] 13. Wu LA, Cooper LT, Kephart GM, Gleich GJ. The eosinophil in cardiac disease. In: Cooper L, editor. Myocarditis: from bench to bedside.Totowa (NJ):Humana Press
  14. p.437-53. [CrossRef] 14. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994
  15. 83(10):2759-79. 15. Ommen SR, Seward JB, Tajik AJ. Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol 2000
  16. 86(1):110-3. [CrossRef] 16. Rizkallah J, Desautels A, Malik A, Zieroth S, Jassal D, Hussain F, et al. Eosinophilic myocarditis: